Lab Data vs Financial Data

Cybersecurity conversations in biotech often begin with financial systems. Payroll platforms, vendor payments, and financial records typically receive the most scrutiny during risk assessments. While those systems are important, executives in research-driven organizations must ask a harder question: Is our lab data actually more valuable to attackers than our financial data? From a threat intelligence […]

Cybersecurity’s Role in Biotech Valuation & Funding

cybersecurity

For biotech executives preparing for funding rounds or strategic partnerships, cybersecurity has quietly moved from a technical issue to a valuation issue. Investors increasingly evaluate operational risk when assessing the stability of a biotech firm. Intellectual property, proprietary research, clinical data, and patient information represent enormous economic value and they are also prime targets for […]

The Real Reason Small MSPs Get Outsold in Cybersecurity

Cybersecurity

Let’s remove the comfortable excuses. You’re not losing deals because: The competitor has better tools The client only cares about brand Your price is “too low to be taken seriously” You’re losing because the buyer believes the other MSP can carry the weight of the outcome. Cybersecurity is not a product sale. It is a […]

Why Better Pricing Doesn’t Win MSP Cybersecurity Deals

MSP Cybersecurity

At some point every small MSP owner asks the same frustrating question: “How did we lose that deal? We were better and cheaper.”  You didn’t lose on price. You lost on perceived risk. And in cybersecurity, the buyer is not purchasing tools, they are transferring liability. The firms winning those deals aren’t always more talented […]

The Cost of a Cybersecurity Breach and Downtime in Biotech

Cybersecurity Breach and Downtime in Biotech

In the biotech industry, every second counts. A single delay in clinical research can set back months of progress, push regulatory submissions off schedule, or jeopardize multi-million-dollar partnerships. That’s why cybersecurity isn’t just a technology investment, it’s a business safeguard. We’ve seen biotech firms learn this lesson the hard way. One midsize company faced a […]

Beyond Antivirus: Comprehensive Solutions for Endpoint Security

Security

Why CEOs Must Rethink Endpoint Protection For decades, antivirus software was seen as the frontline defense against cyber threats. But in today’s digital environment, where attackers are leveraging artificial intelligence, targeting supply chains, and exploiting endpoints that stretch across cloud, mobile, and hybrid environments, antivirus is no longer sufficient. Biotech firms, in particular, face heightened […]

Cybersecurity Threats in Biotech: Staying Ahead of Emerging Risks

Cybersecurity

Why The Biotech Industry Cannot Afford Complacency The biotechnology industry is at the forefront of medical innovation, drug development, and clinical research. But with such innovation comes risk. Intellectual property (IP), sensitive patient data, and proprietary research pipelines are among the most valuable and vulnerable digital assets in the world today. Threat actors, ranging from […]

Is Your Biotech Firm Keeping Pace with Cybersecurity AI Innovation?

AI in Biotech Cybersecurity

In a sector where breakthroughs can define human health outcomes for generations, the protection of sensitive research, intellectual property, and personal health data is non-negotiable. Yet many biotech firms remain unaware that the cybersecurity landscape is undergoing a transformation as significant as their own scientific advancements and it’s being driven by artificial intelligence. From predictive […]

Cyber Threats Facing the Biotech Industry: How to Stay Protected in 2025

Biotech Cybersecurity

The evolving threat landscape in 2025 has forced biotech and life sciences firms to reevaluate their cybersecurity posture. As companies digitize more of their operations from R&D to patient data, they also expand the attack surface available to cybercriminals. While large-scale attacks often make headlines, many biotech firms face daily risks that are just as […]

The MSP Cybersecurity Dilemma: How to Stay Ahead of Threats Without a Dedicated Team

MSP Cybersecurity

MSPs face a cybersecurity dilemma, clients expect enterprise-level security, but building an in-house Security Operations Center (SOC) is expensive, resource-intensive, and often impractical. The increasing sophistication of cyber threats, evolving compliance regulations, and talent shortages make it nearly impossible for smaller IT service firms to provide 24×7 security on their own. So how can MSPs […]

Subscribe to our Podcast